HEOR Staff Writer

HERNEXEOS Lung Cancer Treatment: First FDA Approval for HER2-Mutant NSCLC
KEYTRUDA Padcev MIBC Survival: New Era in Treatment Revealed by KEYNOTE-B15 T...
NICE Approves Ruxolitinib Cream for Treating Vitiligo with Facial Involvement
SAHPRA GMP Compliance: Addressing Allegations Against Adcock Ingram’s C...
Merck Portfolio Optimization: Strategic Reorganization for Enhanced Commercia...
EMA Validation of ENHERTU Breast Cancer Treatment for Post-Neoadjuvant Therapy